Enlivex Therapeutics Ltd. (ENLV) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
8:46 pm
Purchase
2025-06-3013GAutolus Therapeutics plc
AUTL
Armistice Capital, LLC1,178,389
4.990%
1,178,389increase
(New Position)
Filing
History
2025-05-15
3:27 pm
Sale
2025-03-3113GEnlivex Therapeutics Ltd.
ENLV
Armistice Capital, LLC1,781,931
7.530%
-426,069decrease
(-19.30%)
Filing
History
2025-02-14
5:43 pm
Purchase
2024-12-3113GEnlivex Therapeutics Ltd.
ENLV
Armistice Capital, LLC2,208,000
9.750%
32,116increase
(+1.48%)
Filing
History
2024-11-14
3:29 pm
Purchase
2024-09-3013GEnlivex Therapeutics Ltd.
ENLV
Armistice Capital, LLC2,175,884
9.990%
2,175,884increase
(New Position)
Filing
History